| Immediate versus delayed self-reporting of symptoms and side effects during chemotherapy: Does timing matter? | |
| | |
MedLine Citation:
|
PMID: 20685164 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
PURPOSE: The aim of this study was to examine how patients recall symptoms at a delayed self-report. Accurate insight into toxicity symptoms during chemotherapy is essential so that nurses and doctors can assess therapeutic tolerance and adjust supportive care accordingly. METHOD: A non-experimental, longitudinal design was employed. Using the Therapy-Related Symptoms Checklist (TRSC), respondents (n = 142) reported their initial symptoms during the first 7 days of the chemotherapy cycle at two different times: (1) each day of the first seven days after the chemotherapy administration (immediate self-report), and (2) at their next hospital visit for chemotherapy (delayed self-report). We compared the number and severity of symptoms and side effects reported in the immediate and delayed self-reports. RESULTS: Respondents reported significantly fewer symptoms and fewer severe symptoms in the delayed self-report. For 22 out of 25 symptoms the delayed-reported grade was significantly lower than the immediate-reported maximum grade. Compared to the immediate-reported median grade, significant differences occurred in only 10 out of the 25 symptoms. In all cases, except fatigue, the delayed-reported grade was significantly higher than the immediate-reported median grade. CONCLUSIONS: This study indicates that delayed self-report of chemotherapy side effects is not an appropriate measure of actual symptoms and side effects experienced by patients. Delayed self-report gives a weaker insight into actual symptom burden. Fatigue is at particular risk to be minimized at the delayed self-report. Therefore it is recommended to assess chemotherapy-related symptoms and side effects by means of immediate self-report. |
| | |
Authors:
|
Annemarie Coolbrandt; Koen Van den Heede; Ellen Vanhove; Ann De Bom; Koen Milisen; Hans Wildiers |
Related Documents
:
|
8811274 - Photophobia and lithium. 18000964 - Atypical antipsychotics in severe anorexia nervosa in children and adolescents--review ... 19755624 - Evidence-based treatment options for the management of skin toxicities associated with ... 20926454 - Toxic encephalopathy in elderly patients during treatment with capecitabine: literature... 2670704 - Chronic peroneal tendon subluxation produced by an anomalous peroneus brevis: case repo... 20165064 - Photodichroic recording and storage material. |
Publication Detail:
|
Type: Journal Article Date: 2010-08-03 |
Journal Detail:
|
Title: European journal of oncology nursing : the official journal of European Oncology Nursing Society Volume: 15 ISSN: 1532-2122 ISO Abbreviation: Eur J Oncol Nurs Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-03-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100885136 Medline TA: Eur J Oncol Nurs Country: Scotland |
Other Details:
|
Languages: eng Pagination: 130-6 Citation Subset: IM; N |
Copyright Information:
|
Copyright © 2010 Elsevier Ltd. All rights reserved. |
Affiliation:
|
Department of Oncology/Hematology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence.
Next Document: Therapeutic applications of ribozymes and riboswitches.